Table 7.
Effect of VA on serum CK-MB activity and cardiac MDA and GSH contents
Normal | MI control | VA | VA formulation | |
---|---|---|---|---|
CK-MB (U/L) | 111.0 ± 2.3 | 711.0a ± 58.3 | 466.5ab ± 25.1 | 244.0bc ± 56.8 |
MDA (nmol/g) | 35.81 ± 1.2 | 62.04a ± 3.5 | 47.93ab ± 3.7 | 33.61bc ± 2.9 |
GSH (μmol/g) | 3.59 ± 0.3 | 2.15a ± 0.1 | 3.90ab ± 0.4 | 7.05bc ± 0.3 |
The data is presented as mean ± SEM (n = 6)
asignificant difference from normal group
bsignificant difference from MI control group
csignificant difference from VA group (at p < 0.05)